Advertisement
Journal Home
Search for
Cover Image

Current Issue

August 2010 | Vol. 8, No. 8

Top Reports

FDA Advisers: Avandia Can Stay On Market, Needs New Warnings

ACCORD's Outcomes Persist to Study's End

HRS, Other Groups Address End-of-Life Device Deactivation

Side Effects Derail Proposed Drug Combo for Weight Loss

AF Repair During Valve Surgery Boosts Survival

More Reports >>

GMNN Today's News
audio icon    Policy & Practice
video icon    Videos
Blog    EGMN Blog
facebook      Facebook

Colleague Commentary

Heart of the Matter
Dr. Sidney Goldstein discusses lessons learned from the rosiglitazone controversy.

Daily News from Elsevier Global Medical News

Activate Your Online Access to Cardiology News

Sign-up for your free access to Cardiology News online. Browse, search, and share full-text articles with colleagues and patients. For the latest news and research reports from medical meetings and expert commentary, sign up or click here for more information.

Already have a username and password? You may be asked to answer a few questions. Click here to log in.

First-time User? Create an account here, and request free access.

Purchase a print subscription now!

Request Free Access to Full-text

By the Numbers

Vital Signs: Lipid Regulators Now Second-Leading Therapeutic Class

SPECIAL FEATURE

Policy & Practice

On the Beat

RECEIVE FREE E-MAIL ALERTS

Register or login to sign up now to receive each issue's table of contents via e-mail as it becomes available.

Add Table of Contents Alert

Editorial Advisory Board

 

Medical Education Library

Case 1: Management Decisions in an Adult Comorbid Patient With Type 2 Diabetes Having Primary Hyperlipidemia
Case 2: Colesevelam Hydrochloride for Management of a Patient With Type 2 Diabetes Mellitus and Hyperlipidemia

Sponsored by
Daiichi Sankyo, Inc.


Clinical Perspectives in Pulmonary Arterial Hypertension
Sponsored by
Actelion Pharmaceuticals Ltd.


MORE

Advertisement